Improving the quality of care is a passion of ours.

Veralon will help you identify “deal breakers” and “red flags”, understand and evaluate threats to the deal value, and lay the groundwork for a successful future. We have extensive experience in completion of robust due diligence reviews of healthcare transactions between many types of organizations, from both a “buy side” and “sell side” position, all bolstered through our deep, cross-functional expertise in healthcare strategy and finance.

Our team has the experience, analytic capabilities and consensus building skills to help your organization with the emotionally charged decision of whether or not to partner. We understand the sensitivities, as well as the intricacies of the options you have, based on our experience in hundreds of engagements. We will objectively assess whether and how your organization should pursue partnership opportunities and assist you with the strategic option and partnership selection.

Methodological rigor. Getting the deal done. Whether the path of a transaction or capital investment is crystal clear or is in a state of change, Veralon can provide the support you need.

Veralon can help your organization implement and execute a successful bundled payment program. We have helped clients achieve overall average savings of 15% by reducing readmissions by up to 45% and decreasing SNF stays up to 30%. Whether it is BPCI-A or a CMS mandatory bundled payment program, we’ll identify savings opportunities and roadmap a successful path for your organization.

If you want to improve the performance of your existing ACO, or prepare to take on risk, Veralon can help you achieve the best performance possible. We use Quanto, a user friendly web-based tool, to analyze performance and identify opportunities for improvement. With our intuitive tools and guidance, ACO success is not a black box.